Ceredex Value Advisors LLC Sells 76,400 Shares of Select Medical Holdings Co. (NYSE:SEM)

Ceredex Value Advisors LLC decreased its position in Select Medical Holdings Co. (NYSE:SEM) by 23.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 250,350 shares of the health services provider’s stock after selling 76,400 shares during the quarter. Ceredex Value Advisors LLC’s holdings in Select Medical were worth $8,730,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in SEM. Tidal Investments LLC bought a new position in shares of Select Medical in the first quarter valued at approximately $467,000. Capstone Investment Advisors LLC acquired a new stake in shares of Select Medical in the first quarter valued at $690,000. UniSuper Management Pty Ltd bought a new position in shares of Select Medical in the first quarter valued at about $730,000. First Eagle Investment Management LLC grew its holdings in Select Medical by 14.8% during the 1st quarter. First Eagle Investment Management LLC now owns 275,559 shares of the health services provider’s stock worth $8,308,000 after acquiring an additional 35,512 shares during the last quarter. Finally, Hood River Capital Management LLC acquired a new stake in Select Medical in the 2nd quarter valued at about $14,819,000. 89.48% of the stock is owned by institutional investors.

Select Medical Price Performance

SEM opened at $35.95 on Friday. The company has a fifty day moving average price of $34.26 and a two-hundred day moving average price of $34.02. The company has a debt-to-equity ratio of 2.11, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market capitalization of $4.67 billion, a PE ratio of 16.80, a P/E/G ratio of 1.98 and a beta of 1.42. Select Medical Holdings Co. has a 52 week low of $21.28 and a 52 week high of $40.50.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, August 1st. The health services provider reported $0.60 EPS for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 17.56%. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.61 EPS. As a group, analysts anticipate that Select Medical Holdings Co. will post 2.03 earnings per share for the current year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be given a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.39%. Select Medical’s dividend payout ratio is 23.36%.

Analyst Ratings Changes

Several analysts have recently commented on SEM shares. Benchmark reissued a “buy” rating and set a $48.00 price target on shares of Select Medical in a research note on Friday. Bank of America began coverage on Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price for the company. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $39.00.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.